Minor histocompatibility antigens: Past, present, and future

Tissue Antigens

Volumn 84, Issue 4, 2014, Pages 374-360

  Spierings, Eric ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Adoptive immunotherapy; Allo immunity; Graft versus host disease; Graft versus leukemia effect; Hematopoietic stem cell transplantation; Immunogenetics; Minor H antigens; Organ transplantation

Indexed keywords

MINOR HISTOCOMPATIBILITY ANTIGEN;

ALLOGRAFT; GENETICS; GRAFT VERSUS LEUKEMIA EFFECT; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TEST; HUMAN; IMMUNOLOGY; ORGAN TRANSPLANTATION;

ALLOGRAFTS; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; MINOR HISTOCOMPATIBILITY ANTIGENS; ORGAN TRANSPLANTATION;

EID: 84907941382     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12445     Document Type: Review

References (100)

1. Goulmy E, Termijtelen A, Bradley BA, van Rood JJ. Alloimmunity to human H-Y. Lancet 1976: 2: 1206.
2. Wang W, Meadows LR, den Haan JM et al. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science 1995: 269: 1588-90.
3. Pierce RA, Field ED, den Haan JM et al. Cutting edge: the HLA-*A0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique. J Immunol 1999: 163: 6360-4.
4. Goulmy E, Bradley BA, Lansbergen Q, van Rood JJ. The importance of H-Y incompatibility in human organ transplantation. Transplantation 1978: 25: 315-9.
5. Verdijk RM, Kloosterman A, Pool J et al. Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood 2004: 103: 1961-4.
6. Mommaas B, Stegehuis-Kamp JA, Van Halteren AG et al. Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1. Blood 2004: 105: 1823-7.
7. Rosinski KV, Fujii N, Mito JK et al. DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells. Blood 2008: 111: 4817-26.
8. Warren EH, Gavin MA, Simpson E et al. The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen. J Immunol 2000: 164: 2807-14.
9. Goulmy E, Gratama JW, Blokland E, Zwaan FE, van Rood JJ. A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease. Nature 1983: 302: 159-61.
10. van Els CA, D'Amaro J, Pool J et al. Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics 1992: 35: 161-5.
11. den Haan JM, Sherman NE, Blokland E et al. Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 1995: 268: 1476-80.
12. den Haan JM, Meadows LM, Wang W et al. The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science 1998: 279: 1054-7.
13. Vogt MH, de Paus RA, Voogt PJ, Willemze R, Falkenburg JH. DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection. Blood 2000: 95: 1100-5.
14. Vogt MH, Goulmy E, Kloosterboer FM et al. UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T- cell recognition. Blood 2000: 96: 3126-32.
15. Spierings E, Vermeulen C, Vogt MH et al. Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation. Lancet 2003: 362: 610-5.
16. Zorn E, Miklos DB, Floyd BH et al. Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation. J Exp Med 2004: 199: 1133-42.
17. Ivanov R, Aarts T, Hol S et al. Identification of a 40S ribosomal protein S4-derived H-Y epitope able to elicit a lymphoblast-specific cytotoxic T lymphocyte response. Clin Cancer Res 2005: 11: 1694-703.
18. Spierings E, Goulmy E. Minor H antigens in medicine and biology. In: Mehra N, ed. HLA System in Medicine and Biology. New Delhi: Jaypee Brothers Medical Publishers Ltd., 2009, 544-54.
19. Spierings E, Brickner AG, Caldwell JA et al. The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein. Blood 2003: 102: 621-9.
20. Brickner AG, Warren EH, Caldwell JA et al. The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. J Exp Med 2001: 193: 195-206.
21. Spierings E, Gras S, Reiser JB et al. Steric hindrance and fast dissociation explain the lack of immunogenicity of the minor histocompatibility HA-1Arg null allele. J Immunol 2009: 182: 4809-16.
22. Dolstra H, Fredrix H, Maas F et al. A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia. J Exp Med 1999: 189: 301-8.
23. Dolstra H, de Rijke B, Fredrix H et al. Bi-directional allelic recognition of the human minor histocompatibility antigen HB-1 by cytotoxic T lymphocytes. Eur J Immunol 2002: 32: 2748-58.
24. Akatsuka Y, Nishida T, Kondo E et al. Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens. J Exp Med 2003: 197: 1489-500.
25. Kawase T, Nannya Y, Torikai H et al. Identification of human minor histocompatibility antigens based on genetic association with highly parallel genotyping of pooled DNA. Blood 2008: 111: 3286-94.
26. Brickner AG, Evans AM, Mito JK et al. The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL. Blood 2006: 107: 3779-86.
27. Kawase T, Akatsuka Y, Torikai H et al. Alternative splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility antigen. Blood 2007: 110: 1055-63.
28. Murata M, Warren EH, Riddell SR. A human minor histocompatibility antigen resulting from differential expression due to a gene deletion. J Exp Med 2003: 197: 1279-89.
29. de Rijke B, van Horssens-Zoetbrood A, Beekman JM et al. A frame-shift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia. J Clin Invest 2005: 115: 3506-16.
30. Stumpf AN, van der Meijden ED, van Bergen CA, Willemze R, Falkenburg JH, Griffioen M. Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity. Blood 2009: 114: 3684-92.
31. Rotzschke O, Falk K, Wallny HJ, Faath S, Rammensee HG. Characterization of naturally occurring minor histocompatibility peptides including H-4 and H-Y. Science 1990: 249: 283-7.
32. Mommen GP, Frese CK, Meiring HD et al. Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD). Proc Natl Acad Sci U S A 2014: 111: 4507-12.
33. Warren EH, Gavin MA, Xuereb SM et al. A single nucleotide polymorphism in the SP110 nuclear phosphoprotein gene creates a minor histocompatibility antigen whose expression is regulated by interferon-gamma. Blood 2002: 100: 73A.
34. van de Corput L, Chaux P, van der Meijden ED, De Plaen E, Falkenburg FJH, van der Bruggen P. A novel approach to identify antigens recognized by CD4 T cells using complement-opsonized bacteria expressing a cDNA library. Leukemia 2005: 19: 279-85.
35. Griffioen M, Honders MW, van der Meijden ED et al. Identification of 4 novel HLA-B*40:01 restricted minor histocompatibility antigens and their potential as targets for graft-versus-leukemia reactivity. Haematologica 2012: 97: 1196-204.
36. Torikai H, Akatsuka Y, Miyazaki M et al. The human cathepsin H gene encodes two novel minor histocompatibility antigen epitopes restricted by HLA-A*3101 and -A*3303. Br J Haematol 2006: 134: 406-10.
37. Griffioen M, van der Meijden ED, Slager EH et al. Identification of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivity. Proc Natl Acad Sci U S A 2008: 105: 3837-42.
38. Vogt MH, van den Muijsenberg J, Goulmy E et al. The DBY gene codes for an HLA-DQ5 restricted human male specific minor histocompatibility antigen involved in GvHD. Blood 2002: 99: 3027-32.
39. Gubarev MI, Jenkin JC, Leppert MF et al. Localization to chromosome 22 of a gene encoding a human minor histocompatibility antigen. J Immunol 1996: 157: 5448-54.
40. Dausset J, Cann H, Cohen D, Lathrop M, Lalouel JM, White R. Centre d'etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome. Genomics 1990: 6: 575-7.
41. Murray JC, Buetow KH, Weber JL et al. A comprehensive human linkage map with centimorgan density. Cooperative Human Linkage Center (CHLC). Science 1994: 265: 2049-54.
42. Gubarev MI, Jenkin JC, Otterrud BE, Leppert MF, Schallheim JM, Beatty PG. Localization to chromosome 11 of a gene encoding a human minor histocompatibility antigen. Exp Hematol 1998: 26: 976-81.
43. Spaapen RM, Lokhorst HM, van den Oudenalder K et al. Toward targeting B cell cancers with CD4+ CTLs: identification of a CD19-encoded minor histocompatibility antigen using a novel genome-wide analysis. J Exp Med 2008: 205: 2863-72.
44. Kamei M, Nannya Y, Torikai H et al. HapMap scanning of novel human minor histocompatibility antigens. Blood 2009: 113: 5041-8.
45. Spaapen RM, de Kort RA, van den Oudenalder K et al. Rapid identification of clinical relevant minor histocompatibility antigens via genome-wide zygosity-genotype correlation analysis. Clin Cancer Res 2009: 15: 7137-43.
46. Warren EH, Fujii N, Akatsuka Y et al. Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens. Blood 2010: 115: 3869-78.
47. Broen K, Levenga H, Vos J et al. A polymorphism in the splice donor site of ZNF419 results in the novel renal cell carcinoma-associated minor histocompatibility antigen ZAPHIR. PLoS One 2011: 6: e21699.
48. van Bergen CA, Rutten CE, van der Meijden ED et al. High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning. Cancer Res 2010: 70: 9073-83.
49. Oostvogels R, Minnema MC, van Elk M et al. Identification of minor histocompatibility antigens based on the 1000 Genomes Project. Haematologica 2014. http://www.ncbi.nlm.nih.gov/pubmed/25150256.
50. DeLuca DS, Eiz-Vesper B, Ladas N, Khattab BA, Blasczyk R. High-throughput minor histocompatibility antigen prediction. Bioinformatics 2009: 25: 2411-7.
51. Schuler MM, Donnes P, Nastke MD, Kohlbacher O, Rammensee HG, Stevanovic S. SNEP: SNP-derived epitope prediction program for minor H antigens. Immunogenetics 2005: 57: 816-20.
52. Halling-Brown M, Quartey-Papafio R, Travers PJ, Moss DS. SiPep: a system for the prediction of tissue-specific minor histocompatibility antigens. Int J Immunogenet 2006: 33: 289-95.
53. Mommaas B, Kamp J, Drijfhout JW et al. Identification of a novel HLA-B60-restricted T cell epitope of the minor histocompatibility antigen HA-1 locus. J Immunol 2002: 169: 3131-6.
54. Wenandy L, Kollgaard T, Letsch A et al. The 1170 A-P single-nucleotide polymorphism (SNP) in the Her-2/neu protein (HER2) as a minor histocompatibility antigen (mHag). Leukemia 2009: 23: 1926-9.
55. Hombrink P, Hassan C, Kester MG et al. Discovery of T cell epitopes implementing HLA-peptidomics into a reverse immunology approach. J Immunol 2013: 190: 3869-77.
56. Armistead PM, Liang S, Li H et al. Common minor histocompatibility antigen discovery based upon patient clinical outcomes and genomic data. PLoS One 2011: 6: e23217.
57. Mutis T, Blokland E, Kester M, Schrama E, Goulmy E. Generation of minor histocompatibility antigen HA-1-specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation. Blood 2002: 100: 547-52.
58. Spierings E, Hendriks M, Absi L et al. Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations. PLoS Genet 2007: 3: e103.
59. Spierings E. Molecular typing methods for minor histocompatibility antigens. Methods Mol Biol 2014: 1109: 115-38.
60. Goulmy E. Human minor histocompatibility antigens. Curr Opin Immunol 1996: 8: 75-81.
61. Cai J, Lee J, Jankowska-Gan E et al. Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance. J Exp Med 2004: 199: 1017-23.
62. Van Halteren AG, Jankowska-Gan E, Joosten A et al. Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members. Blood 2009: 114: 2263-72.
63. Dierselhuis MP, Jankowska-Gan E, Blokland E et al. HY immune tolerance is common in women without male offspring. PLoS One 2014: 9: e91274.
64. Akatsuka Y, Warren EH, Gooley TA et al. Disparity for a newly identified minor histocompatibility antigen, HA-8, correlates with acute graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling. Br J Haematol 2003: 123: 671-5.
65. McCarroll SA, Bradner JE, Turpeinen H et al. Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease. Nat Genet 2009: 41: 1341-4.
66. Hobo W, Broen K, van der Velden WJ et al. Association of disparities in known minor histocompatibility antigens with relapse-free survival and graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2013: 19: 274-82.
67. Spierings E, Kim YH, Hendriks M et al. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2013: 19: 1244-53.
68. Jervis S, Collins P, Tate D et al. Increased severity of acute graft versus host disease as a result of differential expression following a homozygous gene deletion. Int J Immunogenet 2013: 40: 116-9.
69. Gallardo D, Arostegui JI, Balas A et al. Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation. Br J Haematol 2001: 114: 931-6.
70. Katagiri T, Shiobara S, Nakao S et al. Mismatch of minor histocompatibility antigen contributes to a graft-versus-leukemia effect rather than to acute GVHD, resulting in long-term survival after HLA-identical stem cell transplantation in Japan. Bone Marrow Transplant 2006: 38: 681-6.
71. de Bueger MM, Bakker A, van Rood JJ, Van der Woude F, Goulmy E. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol 1992: 149: 1788-94.
72. Dickinson AM, Wang XN, Sviland L et al. In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens. Nat Med 2002: 8: 410-4.
73. Mutis T, Gillespie G, Schrama E, Falkenburg JH, Moss P, Goulmy E. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat Med 1999: 5: 839-42.
74. Kim YH, Faaij CM, Van Halteren AG et al. In situ detection of HY-specific T cells in acute graft-versus-host disease-affected male skin after sex-mismatched stem cell transplantation. Biol Blood Marrow Transplant 2012: 18: 381-7.
75. Chen Y, Sidney J, Southwood S et al. Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations. J Immunol 1994: 152: 2874-81.
76. Ressing ME, Sette A, Brandt RM et al. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides. J Immunol 1995: 154: 5934-43.
77. Sette A, Vitiello A, Reherman B et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol 1994: 153: 5586-92.
78. van der Burg SH, Visseren MJ, Brandt RM, Kast WM, Melief CJ. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J Immunol 1996: 156: 3308-14.
79. Parker KC, Bednarek MA, Coligan JE. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 1994: 152: 163-75.
80. Goulmy E, Schipper R, Pool J et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996: 334: 281-5.
81. Tseng LH, Lin MT, Hansen JA et al. Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation. Blood 1999: 94: 2911-4.
82. Spellman S, Warden MB, Haagenson M et al. Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants. Biol Blood Marrow Transplant 2009: 15: 856-63.
83. Kim YH, Vyth-Dreese FA, Schrama E et al. Exogenous addition of minor H antigen HA-1+ dendritic cells to skin tissues ex vivo causes infiltration and activation of HA-1 specific cytotoxic T cells. Biol Blood Marrow Transplant 2011: 17: 69-77.
84. Kircher B, Stevanovic S, Urbanek M et al. Induction of HA-1-specific cytotoxic T-cell clones parallels the therapeutic effect of donor lymphocyte infusion. Br J Haematol 2002: 117: 935-9.
85. Marijt WA, Heemskerk MH, Kloosterboer FM et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci U S A 2003: 100: 2742-7.
86. van der Harst D, Goulmy E, Falkenburg J et al. Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones. Blood 1994: 83: 1060-6.
87. Mutis T, Brand R, Gallardo D, van Biezen A, Niederwieser D, Goulmy E. Graft-versus-host driven graft-versus-leukemia effect of minor histocompatibility antigen HA-1 in chronic myeloid leukemia patients. Leukemia 2010: 24: 1388-92.
88. Heinold A, Opelz G, Scherer S et al. Role of minor histocompatibility antigens in renal transplantation. Am J Transplant 2008: 8: 95-102.
89. Dierselhuis MP, Spierings E, Drabbels J et al. Minor H antigen matches and mismatches are equally distributed among recipients with or without complications after HLA identical sibling renal transplantation. Tissue Antigens 2013: 82: 312-6.
90. Gratwohl A, Dohler B, Stern M, Opelz G. H-Y as a minor histocompatibility antigen in kidney transplantation: a retrospective cohort study. Lancet 2008: 372: 49-53.
91. Tan JC, Wadia PP, Coram M et al. H-Y antibody development associates with acute rejection in female patients with male kidney transplants. Transplantation 2008: 86: 75-81.
92. Bohringer D, Spierings E, Enczmann J et al. Matching of the minor histocompatibility antigen HLA-A1/H-Y may improve prognosis in corneal transplantation. Transplantation 2006: 82: 1037-41.
93. Robinson J, Halliwell JA, McWilliam H, Lopez R, Parham P, Marsh SG. The IMGT/HLA database. Nucleic Acids Res 2013: 41: D1222-7.
94. Tykodi SS, Fujii N, Vigneron N et al. C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients. Clin Cancer Res 2008: 14: 5260-9.
95. Bleakley M, Otterud BE, Richardt JL et al. Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells. Blood 2010: 115: 4923-33.
96. van Bergen CA, Kester MG, Jedema I et al. Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene. Blood 2007: 109: 4089-96.
97. Wolfel C, Lennerz V, Lindemann E et al. Dissection and molecular analysis of alloreactive CD8+ T cell responses in allogeneic haematopoietic stem cell transplantation. Cancer Immunol Immunother 2008: 57: 849-57.
98. Oostvogels R, Minnema MC, van Elk M et al. Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1. Leukemia 2013: 27: 642-9.
99. Maiers M, Gragert L, Klitz W. High-resolution HLA alleles and haplotypes in the United States population. Hum Immunol 2007: 68: 779-88.
100. Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 2011: 39: D913-9.